- Home
- CCTG vs NERV Comparison
CCTG vs NERV Comparison
Compare CCTG & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTG
- NERV
- Stock Information
- Founded
- CCTG 1993
- NERV 2007
- Country
- CCTG Hong Kong
- NERV United States
- Employees
- CCTG N/A
- NERV N/A
- Industry
- CCTG
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- CCTG
- NERV Health Care
- Exchange
- CCTG Nasdaq
- NERV Nasdaq
- Market Cap
- CCTG 12.5M
- NERV 12.0M
- IPO Year
- CCTG 2024
- NERV 2014
- Fundamental
- Price
- CCTG $1.13
- NERV $2.40
- Analyst Decision
- CCTG
- NERV Hold
- Analyst Count
- CCTG 0
- NERV 1
- Target Price
- CCTG N/A
- NERV $5.00
- AVG Volume (30 Days)
- CCTG 8.1K
- NERV 41.1K
- Earning Date
- CCTG 09-26-2025
- NERV 08-14-2025
- Dividend Yield
- CCTG N/A
- NERV N/A
- EPS Growth
- CCTG N/A
- NERV N/A
- EPS
- CCTG N/A
- NERV 1.48
- Revenue
- CCTG $17,631,489.00
- NERV N/A
- Revenue This Year
- CCTG N/A
- NERV N/A
- Revenue Next Year
- CCTG N/A
- NERV N/A
- P/E Ratio
- CCTG N/A
- NERV $1.53
- Revenue Growth
- CCTG 19.55
- NERV N/A
- 52 Week Low
- CCTG $0.99
- NERV $1.15
- 52 Week High
- CCTG $3.17
- NERV $3.00
- Technical
- Relative Strength Index (RSI)
- CCTG 57.30
- NERV 63.18
- Support Level
- CCTG $1.07
- NERV $2.26
- Resistance Level
- CCTG $1.12
- NERV $2.47
- Average True Range (ATR)
- CCTG 0.05
- NERV 0.17
- MACD
- CCTG 0.01
- NERV 0.01
- Stochastic Oscillator
- CCTG 45.45
- NERV 75.31
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.